Journal
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
Volume 106, Issue 3, Pages 819-824Publisher
SPRINGER
DOI: 10.1007/s10973-011-1371-6
Keywords
Benznidazole; Compatibility; Differential scanning calorimetry; Fourier transform infrared spectroscopy; Polymorphism; X-ray powder diffractometry
Funding
- CNPq, Brazil [472134/2008-6]
Ask authors/readers for more resources
The purpose of this study was to investigate the polymorphism and compatibility of benznidazole (BNZ), a drug used in the treatment of Chagas disease. This drug was subjected to a polymorphic screen using a number of solvents and precipitation procedures to explore the possible existence of different crystal structures of BNZ. The compatibility of BNZ with selected pharmaceutical excipients was evaluated in binary mixtures, in a ratio of 1:1 (w/w). These results were then analyzed with a variety of techniques, including differential scanning calorimetry, Fourier transform infrared spectroscopy, and X-ray powder diffractometry. No polymorphic forms of BNZ were detected despite some observed changes in the DSC profile. The thermal data indicate interaction of the drug with excipients hydroxyethylcellulose, polyethylene glycol, and hydroxypropyl-beta-cyclodextrin. Additional studies using infrared spectroscopy confirm the incompatibility of BNZ with only the polyethylene glycol. This excipient should not be used in the development of solid dosage forms containing BNZ.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available